T2D is typically characterized by a disruption of proinsulin conversion17, 18 and carriers of T2D-risk alleles generally display increased proinsulin:insulin ratios compared with those who are homozygous for the protective allele.19 The gene discussed is INS; the disease is type 2 diabetes mellitus.